Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients.
about
Haloperidol-induced torsade de pointesCorrected QT interval prolongation associated with intravenous haloperidol in acute coronary syndromes.Clinical pharmacology of old age syndromesTorsade de pointes associated with the administration of intravenous haloperidol:a review of the literature and practical guidelines for use.Antipsychotic drugs and QTc prolongation: the potential role of CYP2D6 genetic polymorphism.A systematic review of cardiovascular effects after atypical antipsychotic medication overdose.Acute disturbed or violent behaviour: principles of treatment.
P2860
Q28375014-DC6718A2-5CA5-45DC-8CEC-7B73D12E48BBQ33957393-5C9F738B-4EEF-442A-A3FE-C87EE2F2A3C2Q35200049-0BDBC205-C66F-4233-B177-208AE871E19CQ35570977-C7409DEE-A80D-4FFA-99AE-D00458B70981Q36725206-F5A744CA-43E9-40B1-A304-27D20BE77D1FQ37381004-33962C30-020C-43E2-8F88-6372615AE85AQ41598547-C7BD6DC6-A663-4694-96AE-321C4FAD3EC2
P2860
Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients.
@en
type
label
Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients.
@en
prefLabel
Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients.
@en
P356
P1433
P1476
Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients.
@en
P2093
Di Salvo TG
P304
P356
10.1002/CLC.4960180512
P577
1995-05-01T00:00:00Z